Clinical trial

Inflammatory Biomarkers for the Diagnosis of oPRES

NCT05433870

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2022-07-01

PhaseN/A

Study timeline

Study start (actual)2022-07-01Date precision: day

Registry last updated2022-08-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Posterior Reversible Encephalopathy Syndromeunresolved

Inflammatory Biomarkersunresolved

Neutrophil-lymphocyte Ratiounresolved

Interventions

Whether the PE or E patient combined with PRESOTHER

Sponsors & collaborators

Dunjin Chenlead sponsor

Mapped research locations

GuangzhouChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05433870 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.